Amy Ladewski, PA-C

NPI: 1083055180
Total Payments
$22,286
2024 Payments
$7,814
Companies
8
Transactions
90
Medicare Patients
543
Medicare Billing
$49,411

Payment Breakdown by Category

Consulting$13,965 (62.7%)
Travel$3,237 (14.5%)
Other$2,937 (13.2%)
Food & Beverage$2,147 (9.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $13,965 20 62.7%
Travel and Lodging $3,237 6 14.5%
Food and Beverage $2,147 60 9.6%
Honoraria $2,037 2 9.1%
Compensation for serving as faculty or as a speaker for a medical education program $900.00 2 4.0%

Top Paying Companies

Company Total Records Latest Year
Ardelyx, Inc. $12,196 26 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $3,506 37 $0 (2024)
ABBVIE INC. $3,087 5 $0 (2024)
Phathom Pharmaceuticals, Inc. $2,974 15 $0 (2024)
Mahana Therapeutics, Inc. $357.00 1 $0 (2022)
Regeneron Healthcare Solutions, Inc. $91.88 1 $0 (2023)
Celgene Corporation $61.27 4 $0 (2023)
QOL Medical, LLC $13.71 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,814 16 Ardelyx, Inc. ($4,551)
2023 $11,002 43 Ardelyx, Inc. ($5,550)
2022 $3,245 20 Ardelyx, Inc. ($2,096)
2021 $225.56 11 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($211.85)

All Payment Transactions

90 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
09/27/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,375.00 General
08/30/2024 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $250.00 General
Category: GASTROENTEROLOGY
08/28/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,650.00 General
08/21/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $88.53 General
Category: GASTROENTEROLOGY
08/20/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $21.58 General
Category: GASTROENTEROLOGY
08/14/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $18.68 General
Category: GASTROENTEROLOGY
08/02/2024 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $250.00 General
Category: GASTROENTEROLOGY
07/18/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $20.82 General
Category: GASTROENTEROLOGY
06/18/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $20.19 General
Category: ENDOCRINOLOGY
06/11/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.07 General
Category: GASTROENTEROLOGY
06/11/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $8.54 General
Category: GASTROENTEROLOGY
04/24/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $21.32 General
Category: GASTROENTEROLOGY
04/19/2024 Ardelyx, Inc. Consulting Fee Cash or cash equivalent $1,750.00 General
03/22/2024 Ardelyx, Inc. Travel and Lodging In-kind items and services $1,925.50 General
01/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $24.92 General
Category: Gastroenterology
01/26/2024 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $375.00 General
Category: GASTROENTEROLOGY
12/19/2023 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $23.38 General
Category: GASTROENTEROLOGY
12/15/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug), VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK Honoraria Cash or cash equivalent $1,680.00 General
Category: GASTROENTEROLOGY
12/14/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), PLENVU Food and Beverage In-kind items and services $29.27 General
Category: Gastroenterology
12/01/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $58.64 General
Category: GASTROENTEROLOGY
12/01/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $54.99 General
Category: GASTROENTEROLOGY
12/01/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Travel and Lodging In-kind items and services $37.50 General
Category: GASTROENTEROLOGY
12/01/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $32.55 General
Category: GASTROENTEROLOGY
11/30/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Travel and Lodging In-kind items and services $443.88 General
Category: GASTROENTEROLOGY
11/30/2023 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Travel and Lodging In-kind items and services $261.33 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 113 145 $43,989 $12,135
2022 4 138 166 $52,219 $14,267
2021 3 121 138 $40,261 $11,456
2020 4 171 204 $48,972 $11,553
Total Patients
543
Total Services
653
Medicare Billing
$49,411
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 70 95 $31,825 $9,156 28.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 22 28 $6,664 $1,654 24.8%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2023 21 22 $5,500 $1,325 24.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 68 87 $29,145 $8,317 28.5%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2022 26 34 $8,500 $2,245 26.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 30 31 $7,378 $2,071 28.1%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 14 14 $7,196 $1,633 22.7%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 63 73 $24,455 $7,329 30.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 32 37 $8,806 $2,432 27.6%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2021 26 28 $7,000 $1,695 24.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 50 60 $20,100 $4,494 22.4%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 54 67 $16,750 $3,897 23.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 37 44 $10,472 $2,261 21.6%
98968 Telephone assessment and management service, 21-30 minutes of medical discussion Facility 2020 30 33 $1,650 $900.56 54.6%

About Amy Ladewski, PA-C

Amy Ladewski, PA-C is a Physician Assistant healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083055180.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Ladewski, PA-C has received a total of $22,286 in payments from pharmaceutical and medical device companies, with $7,814 received in 2024. These payments were reported across 90 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($13,965).

As a Medicare-enrolled provider, Ladewski has provided services to 543 Medicare beneficiaries, totaling 653 services with total Medicare billing of $49,411. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Other Specialties Medical
  • Location Chicago, IL
  • Active Since 07/17/2013
  • Last Updated 07/16/2024
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1083055180

Products in Payments

  • IBSRELA (Drug) $8,521
  • VOQUEZNA (Drug) $2,974
  • RELISTOR (Drug) $1,716
  • XIFAXAN (Drug) $973.54
  • TRULANCE (Drug) $744.93
  • DUPIXENT (Biological) $91.88
  • ZEPOSIA (Drug) $61.27
  • VIBERZI (Drug) $42.17
  • CREON (Drug) $20.19
  • SUCRAID (Drug) $13.71

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Chicago